{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
<< Go to the CME website
Beaumont Health
  • Sign In
  • Courses
  • On Demand
  • Grand Rounds Calendar
  • State Required CE
  • About Us
  • Planner Resources
  • Help
Close Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Corewell Health users: Click "Sign in with your Organization ID" | All Others - click "Sign in with your email and CME portal password".

If you are accessing from a non-Corewell Health computer or device, you must be enrolled in PING.  Enter your Corewell Health network credentials when prompted. 
CLICK HERE for FAQs and PING Enrollment Instructions

Sign in with your Organization ID
Sign in with your email and CME portal password
Enter your email and password to login:

*
*
Login

New to CloudCME? Create an Account:

Create New Account
Back to Login Provider Forgot Your Password?

Forgot Your Password?







Back to Login
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##
Email is required Invalid: Enter valid email address
First Name is required
Last Name is required
Password is required


Password Requirements

  • Must be between 8 and 16 characters in length
  • Must Contain at least 1 upper case character
  • Must Contain at least 1 lower case character
  • Must contain at least 1 numeric character
  • Must contain at least 1 of the following ! * @ # $ % ^ & + =
Confirm password

Passwords must match
Password must be between 8 and 16 characters and contain the following:
•at least 1 upper case character
•at least 1 lower case character
•at least 1 numerical character
•at least 1 special character

  • -- Select Degree --
  • ADN
  • BA
  • BS
  • BSN
  • CNM
  • CPhT
  • CRNA
  • DC
  • DDS
  • DMD
  • DNP
  • DO
  • DPM
  • DTR
  • FRCS
  • LCSW
  • LPN
  • MA
  • MBA
  • MBChB
  • MD
  • MD, PhD
  • MHA
  • MPH
  • MS
  • MSN
  • MSW
  • ND
  • None
  • NP
  • OD
  • OT
  • Other
  • PA
  • PA-C
  • PharmD
  • PhD
  • PsyD
  • PT
  • PTA
  • RD
  • RDMS
  • RN
  • RPh
  • RT
  • RVT
Degree is required
Please enter your degree:
You must enter a degree

Profession is required




Back to Login
Close Search Site Search: Enter your search terms in the field below to view results.

please enter a term to search
Close Specialties
{1}
##LOC[OK]##
{1}
##LOC[OK]## ##LOC[Cancel]##
{1}
##LOC[OK]## ##LOC[Cancel]##

Vit-Buckle Society 8 Virtual Series Part 1: When You Play the Game of Thrones

  • Overview
  • Faculty


Date & Location
Thursday, October 1, 2020, 12:00 AM - Friday, October 1, 2021, 12:00 AM

Overview

Vit-Buckle Society Virtual Series Part 1 features a discussion of COVID-19 impact on academic and private retina institutions, pearls for subretinal gene therapy surgery and pneumatic retinopexy, first-time presentation of clinical trial results, and classic surgical debate.

Release Date: October 1, 2020  |  Expiration Date: September 30, 2021
Estimated Time to Complete: 80 minutes

Moderated by Mrinali Gupta, MD; R. Ross Lakhanpal, MD; Jayanth Sridhar, MD; Charles Wykoff, MD, PhD, Yoshihiro Yonekawa, MD

  • Introduction - R. Ross Lakhanpal, MD
  • COVID-19 Impact in NYC - Royce Chen, MD
  • Practice Management during the COVID-19 Pandemic  - James Vander, MD
  • Thinking Outside the Bubble with Pneumatic Retinopexy - Rajeev Muni, MD, MSC, FRCS(c)
  • Subretinal Gene Therapy Surgery - Ninel Gregori, MD
  • Medical Retina: A Novel Tyrosine Kinase Inhibitor Hydrogel Intravitreal Implant (OTX-TKI):
  • First Time Data Release - Robert Avery, MD
  • Medical Retina: Delivering Anti-VEGF Pharmacotherapy with Gene Therapy: Update on Clinical Trial Data - Robert Avery, MD
  • ILM Peeling for RRD Debate, PRO - Gaurav Shah, MD
  • ILM Peeling for RRD Debate, CON - Caroline Baumal, MD
  • Concluding Remarks - Charles Wykoff, MD, PhD

Target Audience
Specialties - Ophthalmology
Professions - Physician

Objectives
  1. Formulate a practice management plan to address the COVID-19 pandemic.
  2. Evaluate and treat patients with retinal detachment with pneumatic retinopexy.
  3. Describe gene therapy principles.

Registration
Click Brochure tab for instructions on how to complete the module.

Credits
AMA PRA Category 1 Credits™ (1.25 hours), AMA PRA Non-Physician (Attendance) (1.25 hours)

Credit Information

In support of improving patient care, this activity has been planned and implemented by Beaumont Health and Medical Conference Planners, Inc.  Beaumont Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Medicine CME: Beaumont Health designates this enduring activityfor a maximum of 1.25 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Additional Information

References:
www.vitbucklesociety.org/vit-buckle-academy
 
www.retinapodcast.com

Commercial Support: This module is supported by educational grants from Alcon Vision, LLC; Bausch + Lomb; and Regeneron Pharmaceuticals Inc.

 

Click to Return to VBS8 Main Page



Keywords: AMA



Disclosures: Please click the faculty name to review the individual's financial relationships with commercial interests.

Member Information
Role in activity
Nature of Relationship(s) / Name of Ineligible Company(s)
Robert Avery, MD
California Retina Consultants
Faculty
Consultant/Advisor-Genentech, Inc.|Research Grant-Genentech, Inc.|Consultant/Advisor-Allergan|Consultant/Advisor-Novartis AG|Stock Ownership-Novartis AG|Consultant/Advisor-Apellis|Consultant/Advisor-Alimera|Consultant/Advisor-Amgen|Consultant/Advisor-Ocular Therapeutix|Consultant/Advisor-RegenXbio|Consultant/Advisor-Santen|Consultant/Advisor-iridex|Stock Ownership-Regeneron|Intellectual Property Rights/Patent Holder-Replenish|Consultant/Advisor-Replenish|Stock Ownership-Replenish|Consultant/Advisor-Eyepoint Pharma|Consultant/Advisor-Clearside|Consultant/Advisor-Helio Vision|Consultant/Advisor-Johnson and Johnson-Johnson and Johnson|Consultant/Advisor-Pr3vent Medical AI|Stock Ownership-Visionary Ventures|Consultant/Advisor-Visionary Ventures|Consultant/Advisor-InFocus Capital Partners|Stock Ownership-InFocus Capital Partners
Caroline Baumal, MD
new england eye
Faculty
Speakers Bureau-Genentech, Inc.|Speakers Bureau-Novartis AG|Speakers Bureau-Zeiss|Consultant/Advisor-Ocular therapeutics
Royce Chen, MD
Columbia University
Faculty
Consultant/Advisor-Carl Zeiss Meditec|Consultant/Advisor-Allergan|Consultant/Advisor-Alimera
Ninel Gregori, MD
University of Miami
Faculty
Consultant/Advisor-Astellas Regenerative Medicine|Research Grant-Biogen Idec
Mrinali Gupta, MD
Weill Cornell Medical College
Faculty
Consultant/Advisor-Genentech, Inc.|Consultant/Advisor-Regeneron|Consultant/Advisor-Alcon|Consultant/Advisor-Carl Zeiss Inc|Intellectual Property Rights/Patent Holder-Sonder Research X
Rohit Lakhanpal, MD
RCC/RGW
Faculty
Nothing to disclose
Rajeev Muni, MD, MSc, FRCSC
Univ of Toronto
Canada
Faculty
Nothing to disclose
Faculty Photos
Gaurav Shah, MD
West coast retina
Faculty
grants, honoria-DORC|advisory board, consultant, speaker-Regeneron |Speakers Bureau-Bausch and Lomb|advisory board, consultant -Allergan |Speaker/grants/honoraria-Dutch Ophthalmics
Jayanth Sridhar, MD
Bascom Palmer Eye Institute
Faculty
Consultant/Advisor-Alimera Science|Consultant/Advisor-Novartis AG|Consultant/Advisor-Allergan|Consultant/Advisor-Regeneron
James Vander, MD
Faculty
Nothing to disclose
Charles Wykoff, MD, PhD
Retina Consultants of Texas
Faculty
Consultant/Advisor-Acucela|Consultant/Advisor-Adverum|Consultant/Advisor-Aerpio|Consultant/Advisor-Alimera Sciences|Consultant/Advisor-Allegro|Consultant/Advisor-Allergan|Consultant/Advisor-Apellis|Consultant/Advisor-Bayer Corporation|Consultant/Advisor-Chengdu Kanghong|Consultant/Advisor-Clearside Biomedical|Consultant/Advisor-DORC|Consultant/Advisor-EyePoint|Consultant/Advisor-Genentech/Roche|Consultant/Advisor-Iveric Bio|Consultant/Advisor-Kodiak|Consultant/Advisor-Novartis|Consultant/Advisor-ONL Therapeutics|Consultant/Advisor-Oxurion|Consultant/Advisor-PolyPhotonix|Consultant/Advisor-Recens Medical|Consultant/Advisor-Regeneron|Consultant/Advisor-RegenxBio|Consultant/Advisor-Santen|Consultant/Advisor-Takeda|Research Grant-Adverum|Research Grant-Aerie Pharmaceuticals|Research Grant-Aerpio|Research Grant-Allergan|Research Grant-Apellis|Research Grant-Chengdu Kanghong|Research Grant-Clearside Biomedical|Research Grant-Gemini Therapeutics|Research Grant-Genentech/Roche|Research Grant-Graybug Vision|Research Grant-IONIS Pharmaceuticals|Research Grant-Iveric Bio|Research Grant-Kodiak|Research Grant-Neurotech|Research Grant-Novartis|Research Grant-Opthea|Research Grant-Outlook Therapeutics|Research Grant-Recens Medical|Research Grant-Regeneron|Research Grant-RegenxBio|Research Grant-Samsung|Research Grant-Santen|Research Grant-Xbrane Biopharma|Speakers Bureau-Regeneron
Yoshihiro Yonekawa, MD
Wills Eye Hospital / Mid Atlantic Retina
Faculty
Consultant/Advisor-Alcon



corewellhealth.org/cmesoutheast